Reversal of a Blunted Follicle-Stimulating Hormone by Chemotherapy in an Inhibin B–Secreting Adrenocortical Carcinoma - Normandie Université Access content directly
Journal Articles Journal of the Endocrine Society Year : 2017

Reversal of a Blunted Follicle-Stimulating Hormone by Chemotherapy in an Inhibin B–Secreting Adrenocortical Carcinoma

Abstract

Adrenocortical carcinomas (ACCs) are revealed in 60% of cases by steroid hypersecretion. Alternatively, it is uncommon to observe a paraneoplastic syndrome due to a peptide oversecretion.

Dates and versions

hal-01945843 , version 1 (05-12-2018)

Identifiers

Cite

Stéphanie Espiard, Najiba Lahlou, Mathilde Sibony, Estelle Louiset, Marie Bienvenu, et al.. Reversal of a Blunted Follicle-Stimulating Hormone by Chemotherapy in an Inhibin B–Secreting Adrenocortical Carcinoma. Journal of the Endocrine Society, 2017, 1 (1), pp.46-50. ⟨10.1210/js.2016-1009⟩. ⟨hal-01945843⟩
34 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More